A Study to Evaluate Safety, Tolerability, and Immunogenicity of an Investigational Zoster Vaccine In Subjects With a History of Varicella (Chickenpox)(V211-010)(COMPLETED)

Condition:   Herpes ZosterInterventions:   Biological: Comparator: zoster vaccine live (Oka/Merck) refrigerated formulation;   Biological: Comparator: zoster vaccine live (Oka/Merck) frozen formulationSponsor:   Merck Sharp & Dohme Corp.Completed - verified January 2015
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials